Antimicrobial Resistance Surveillance - Global Strategic Business Report

The global market for Antimicrobial Resistance Surveillance was valued at US$6.1 Billion in 2025 and is projected to reach US$8.6 Billion by 2032, growing at a CAGR of 5.1% from 2025 to 2032. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Global Antimicrobial Resistance Surveillance Market - Key Trends & Drivers Summarized

How Is the Growing Threat of Superbugs Shaping AMR Surveillance?

Antimicrobial resistance (AMR) is a global public health crisis, with drug-resistant infections projected to cause 10 million deaths annually by 2050 if left unchecked. The increasing prevalence of multi-drug resistant (MDR) bacteria, fungi, viruses, and parasites has accelerated the demand for robust AMR surveillance systems worldwide. Governments, healthcare institutions, and pharmaceutical companies are investing in early detection mechanisms, genome sequencing, and real-time data analytics to track and mitigate resistance patterns. The World Health Organization's Global Antimicrobial Resistance and Use Surveillance System (GLASS) has been pivotal in standardizing surveillance approaches across nations. However, many low-resource countries still face challenges in data collection, laboratory infrastructure, and diagnostic capabilities, necessitating innovative mobile-based and AI-powered solutions to enhance AMR tracking.

Can Cutting-Edge Technologies Redefine AMR Surveillance?

The rapid advancements in next-generation sequencing (NGS), machine learning algorithms, and big data analytics have revolutionized AMR surveillance, allowing for faster and more precise identification of resistant pathogens. AI-driven predictive models are now being integrated with electronic health records (EHRs) to track AMR trends in real-time, helping clinicians make informed treatment decisions. Moreover, point-of-care diagnostics and wearable biosensors are improving early resistance detection in both clinical and community settings. Cloud-based platforms enable global data sharing, fostering international collaborations and reinforcing preparedness against AMR outbreaks. The introduction of blockchain technology in AMR data management is also enhancing transparency and reliability, ensuring accurate tracking of antimicrobial usage and resistance evolution.

What Are the Challenges in Expanding AMR Surveillance to All Regions?

Despite advancements, several barriers hinder the global expansion of AMR surveillance. Limited funding, lack of skilled personnel, and regulatory disparities remain major challenges, particularly in low- and middle-income countries (LMICs). Additionally, over-the-counter antibiotic sales, self-medication practices, and poor hospital infection control policies contribute to the silent spread of resistance, making surveillance efforts more complex. The growing presence of zoonotic AMR pathogens in livestock and food supply chains demands stronger One Health approaches, integrating human, animal, and environmental surveillance under a unified system. Ensuring uniform reporting standards, real-time data access, and collaboration between government agencies and private healthcare providers is imperative for tackling AMR effectively on a global scale.

What's Fueling the Growth of the Antimicrobial Resistance Surveillance Market?

The growth in the antimicrobial resistance surveillance market is driven by several factors, including the rising burden of drug-resistant infections, increasing adoption of genomic sequencing technologies, and government-led surveillance initiatives. The pharmaceutical industry is actively investing in companion diagnostics and resistance profiling tools, fostering the development of next-generation antibiotics and alternative therapies. The increasing demand for AI-integrated surveillance platforms, predictive analytics, and blockchain-based tracking systems is further bolstering market expansion. Moreover, stringent regulatory guidelines mandating antibiotic stewardship programs and real-time AMR reporting are propelling investments in surveillance infrastructure. The growing focus on precision medicine, rapid diagnostic tests, and One Health frameworks will continue to drive the AMR surveillance market, positioning it as a cornerstone in the global fight against antimicrobial resistance.

Report Scope

The report analyzes the Antimicrobial Resistance Surveillance market, presented in terms of market value (US$). The analysis covers the key segments and geographic regions outlined below:

• Segments: Solution (Diagnostic Kits, Diagnostic Systems, Diagnostics Software, Diagnostic Services); Application (Clinical Diagnostics Application, Public Health Surveillance Application, Laboratory Surveillance Application); End-Use (Hospitals End-Use, Clinics End-Use, Other End-Uses).
• Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Key Insights:

• Market Growth: Understand the significant growth trajectory of the Diagnostic Kits segment, which is expected to reach US$4.4 Billion by 2032 with a CAGR of a 5.8%. The Diagnostic Systems segment is also set to grow at 4.9% CAGR over the analysis period.
• Regional Analysis: Gain insights into the U.S. market, valued at $1.6 Billion in 2025, and China, forecasted to grow at an impressive 8.9% CAGR to reach $1.9 Billion by 2032. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

• Detailed Market Analysis: Access a thorough analysis of the Global Antimicrobial Resistance Surveillance Market, covering all major geographic regions and market segments.
• Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
• Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Antimicrobial Resistance Surveillance Market.
• Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

• How is the Global Antimicrobial Resistance Surveillance Market expected to evolve by 2032?
• What are the main drivers and restraints affecting the market?
• Which market segments will grow the most over the forecast period?
• How will market shares for different regions and segments change by 2032?
• Who are the leading players in the market, and what are their prospects?

Report Features:

• Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2025 to 2032.
• In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
• Company Profiles: Coverage of players such as Accelerate Diagnostics, Inc., Becton, Dickinson and Company, bioMerieux SA, Bio-Rad Laboratories, Inc., Bruker Corporation and more.
• Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Some of the companies featured in this Antimicrobial Resistance Surveillance market report include:

• Accelerate Diagnostics, Inc.
• Becton, Dickinson and Company
• bioMerieux SA
• Bio-Rad Laboratories, Inc.
• Bruker Corporation
• Cepheid
• Diasorin S.P.A.
• Liofilchem S.r.l.
• Merck & Co., Inc.
• Pfizer, Inc.
• Qiagen NV

What Sets This Report Apart From Others?

• Grounded in Domain Expert Perspectives: Incorporates perspectives emerging from domain experts across industry, enterprise and academia, adding context beyond conventional published research.
• Captures Early Market Signals: Tracks shifts emerging through expert conversations, company activity and market-relevant discussions before they are fully reflected in traditional secondary research.
• Draws From a Broad, Validated Intelligence Base: Brings together insights from conference sessions, keynotes, panel discussions, blogs, corporate disclosures, annual reports, institutional publications and other validated sources.
• Connects Signals With Strategic Market Direction: Synthesizes these perspectives to identify where the market is moving, what is driving that movement and which developments are likely to matter most for strategy.
• Provides In-Depth Company Intelligence: Extends beyond market-level analysis to examine the companies participating in and shaping the competitive environment.
• Market Share Is Examined Where It Matters: A single global market share figure rarely tells the full story. Competitive structures can vary significantly across geographies. Where analytically relevant, our reports extend market share analysis into major regions with the level of detail tailored to the structure and dynamics of each market.